Market News & Trends
Catalent to Collaborate on SMARTag
Catalent Pharma Solutions recently announced it has entered into a collaboration with Sanofi-Aventis Recherche & Développement, a Sanofi Company (EURONEXT: SAN) (NYSE: SNY) to implement…
FREE WEBINAR - Analysts Predict a Big Year for Healthcare in 2015!
Find out what lies ahead as Frost & Sullivan’s healthcare futurists offer their bold predictions for the entire healthcare industry WHEN …
Denmark’s Pharmaceutical Market Value to Decline to $3 Billion by 2020
Denmark’s pharmaceutical market will decline in value from $3.5 billion in 2013 to $3 billion by 2020, with price-cap agreements and high tax rates on…
Frost & Sullivan Releases Drug Launch Phase III Trial Watch List for Top Therapeutic Areas
The therapeutics market is buzzing with activity, as several promising therapies are progressing to Phase III clinical trials and many more are awaiting commercial launches.…
Global Cancer Vaccine Market to Reach $4.3 Billion in 2019
BCC Research recently announced in its new report, Cancer Vaccines: Technologies and Global Markets, the global market for cancer vaccines is expected to grow to…
goBalto Announces Latest Release of goBalto Activate
goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, recently announced the release of its latest version of goBalto Activate, its flagship study startup…
Capsugel Acquires Ionic Liquids Technology
Morristown, N.J., and Melbourne, Australia – Capsugel and Monash University recently announced that Capsugel has acquired the intellectual property pertaining to proprietary Ionic Liquids Technology…
Moderna Launches New Venture for Infectious Diseases
Moderna Therapeutics recently announced the launch of Valera LLC, a new Moderna venture focused exclusively on the advancement of vaccines and therapeutics for the prevention…
Surface Oncology Announces $35-Million Financing to Advance Next-Generation Cancer Immunotherapies
Surface Oncology recently announced it has closed a $35-million Series A investment round led by Atlas Venture, which initially seeded the company in 2014, Fidelity…
Lyophilization Services of New England Receives Approval to Manufacture Commercial Aseptic Product
Lyophilization Services of New England, Inc. (LSNE) recently announced that following an FDA Pre-Approval Inspection (PAI) in November 2014, their Harvey Road manufacturing site has…
Blend Therapeutics Secures $21 Million and Unveils Novel Pentarin Platform
Blend Therapeutics, Inc. recently announced it has secured $21 million in new funding. The new financing includes additional equity investment from a new investor and…
Amgen & Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration
Amgen (NASDAQ:AMGN) and Kite Pharma (NASDAQ:KITE) recently announced the two companies have entered into a strategic research collaboration and license agreement to develop and commercialize…
Incyte & Agenus Announce Global Alliance to Develop Novel Immuno-Oncology Antibodies
Incyte Corporation and Agenus Inc. recently announced a global license, development, and commercialization agreement focused on novel immuno-therapeutics using Agenus’ proprietary Retrocyte Display antibody discovery…
Record Number of Medicines for Rare Diseases Recommended for Approval in 2014
In 2014, the European Medicines Agency (EMA) recommended the highest number of orphan designated medicines for marketing authorisation in a year. Out of the 82…
Recently Discovered Super-Antibiotic Hailed as a Game-Changer
By: Anna Azvolinsky | January 7, 2015 | The Scientist Many of the most widely used antibiotics have come out of the dirt. Penicillin…
ARIAD & Otsuka Announce Co-Development & Commercialization Agreement
ARIAD Pharmaceuticals, Inc. and Otsuka Pharmaceutical Co., Ltd. recently announced they have entered into an agreement for Otsuka to commercialize ARIAD’s Iclusig (ponatinib) in Japan…
Actavis Confirms Receipt of Complete Response Letter
Actavis plc recently confirmed it has received a complete response letter from the US FDA for its New Drug Application (NDA) for the fixed-dose combination…
Gilead Announces Amended Agreements With Janssen
Gilead Sciences, Inc. recently announced an expansion to its agreement with Janssen R&D Ireland for the development and commercialization of a new once-daily single tablet…
Roche to Acquire Dutalys to Augment Development Pipeline
Roche recently announced it has agreed to acquire Dutalys GmbH, which specializes in the discovery and development of fully human, bi-specific antibodies based on its…
Phylogica Enters Research & Licensing Agreement With Genentech
Phylogica Ltd. recently announced it has extended its collaboration with Genentech, a member of the Roche Group, by entering into a Research and Licensing agreement…
